Related Experiment Videos
A comparison of the biological activities of wild-type and mutant p53
1Department of Molecular Biology, Princeton University, New Jersey 08544.
Abstract:
Tumorigenesis is characterized by a series of genetic alterations in both dominant oncogenes and tumor suppressor genes. A hallmark of tumor suppressor genes is that both alleles are generally altered during transformation, which usually represents a loss of function phenotype. The p53 tumor suppressor gene is the most frequently affected gene detected in human cancer. There is now growing evidence suggesting that mutation of p53 may involve not only a loss of function of wild-type p53 activity but also a gain of function phenotype contributed by the mutant p53 protein. The study of the biological properties and functions of both wild-type and mutant p53 is central to our understanding of human cancer. These properties and functions of wild-type and mutant p53 will be compared and contrasted here and elsewhere within this thematic issue. In addition, the mechanisms of inactivation of p53 function, which include: 1) mutation, 2) inhibition by viral oncogene products, 3) inhibition by cellular regulators, and 4) alteration in subcellular localization, will be discussed.
Insights
Tumor suppressor genes like p53 are crucial in cancer. Mutations in p53 can lead to both loss and gain of function, impacting tumor development and offering targets for cancer therapy.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Tumorigenesis involves genetic alterations in oncogenes and tumor suppressor genes.
- Tumor suppressor gene inactivation typically results in a loss of function.
- The p53 tumor suppressor gene is frequently altered in human cancers.
Purpose of the Study:
- To compare and contrast the biological properties and functions of wild-type and mutant p53.
- To discuss mechanisms of p53 inactivation in cancer.
Main Methods:
- Review and synthesis of existing evidence on p53 function and inactivation.
- Comparative analysis of wild-type versus mutant p53 activities.
- Discussion of various p53 inactivation pathways.
Main Results:
- Evidence suggests p53 mutations can cause both loss of wild-type function and gain of novel oncogenic functions.
- Multiple mechanisms contribute to p53 inactivation, including mutation, viral proteins, cellular regulators, and altered localization.
Conclusions:
- Understanding wild-type and mutant p53 functions is central to cancer biology.
- p53 inactivation mechanisms are diverse and critical for tumorigenesis.